Florida Senate - 2012 SB 324
By Senator Bullard
39-00273-12 2012324__
1 A bill to be entitled
2 An act relating to congenital craniofacial anomalies;
3 requiring the Agency for Health Care Administration,
4 in consultation with the Office of Insurance
5 Regulation, to conduct a study concerning the medical
6 necessity, costs, and efficacy of mandating coverage
7 for certain treatments and therapies; requiring that
8 the agency report its findings and recommendations to
9 the Legislature; providing an appropriation; providing
10 an effective date.
11
12 Be It Enacted by the Legislature of the State of Florida:
13
14 Section 1. (1) The Agency for Health Care Administration,
15 in consultation with the Office of Insurance Regulation, shall
16 conduct a study evaluating the medical necessity, efficacy, and
17 costs of requiring health insurers and health maintenance
18 organizations to provide coverage for cranial-skull-molding
19 orthotics and other therapies used in the treatment of
20 deformational or positional plagiocephaly. The agency and office
21 shall evaluate whether gaps in coverage currently exist in the
22 small and large group insurance markets for medically necessary
23 care and treatment of plagiocephaly. The agency shall provide
24 information concerning the types of benefits, including the cost
25 of such benefits, provided to Medicaid recipients for the
26 treatment of plagiocephaly and the demographic characteristics
27 of such Medicaid recipients. The Department of Health shall
28 coordinate with the agency to provide such information
29 concerning coverage and the costs of providing such coverage to
30 children who have plagiocephaly and who are enrolled in the
31 Children’s Medical Services Program.
32 (2) The agency, in consultation with the office, may
33 contract with an actuary who is a member of the American Academy
34 of Actuaries and other persons who have an extensive background
35 in health insurance for the purpose of assisting the agency in
36 evaluating the medical necessity, efficacy, and costs of such
37 coverage. The agency shall report its findings and
38 recommendations related to mandating insurance coverage for the
39 treatment of plagiocephaly to the President of the Senate and
40 the Speaker of the House of Representatives by January 1, 2013.
41 Section 2. For the 2012-2013 fiscal year, the sum of
42 $25,000 is appropriated in nonrecurring funds from the Insurance
43 Regulatory Trust Fund to the Office of Insurance Regulation for
44 the purpose of funding the study conducted by the Agency for
45 Health Care Administration as provided in this act.
46 Section 3. This act shall take effect July 1, 2012.